Vanover Kimberly E. 4
4 · Intra-Cellular Therapies, Inc. · Filed Jan 5, 2018
Insider Transaction Report
Form 4
Vanover Kimberly E.
VP, Clinical Development
Transactions
- Exercise/Conversion
Common Stock
2018-01-03+2,648→ 12,776 total - Exercise/Conversion
Common Stock
2018-01-04+1,554→ 14,330 total - Sale
Common Stock
2018-01-05$17.37/sh−1,185$20,583→ 13,145 total - Exercise/Conversion
Restricted Stock Units
2018-01-03−2,648→ 5,298 total→ Common Stock (2,648 underlying) - Exercise/Conversion
Restricted Stock Units
2018-01-04−1,554→ 1,554 total→ Common Stock (1,554 underlying) - Award
Restricted Stock Units
2018-01-03+48,480→ 48,480 total→ Common Stock (48,480 underlying) - Award
Stock Option (right to buy)
2018-01-03+65,164→ 65,164 totalExercise: $15.47Exp: 2028-01-03→ Common Stock (65,164 underlying)
Footnotes (8)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2017. The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.97 to $17.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F5]On January 3, 2017, the reporting person was granted 7,946 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F6]On January 4, 2016, the reporting person was granted 4,661 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F7]On January 3, 2018, the reporting person was granted options to purchase 65,164 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F8]On January 3, 2018, the reporting person was granted 48,480 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.